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Introduction. End-stage ankle osteoarthritis is a debilitating condition. Traditionally, ankle arthrodesis (AA) has been the surgical
intervention of choice but the emergence of total ankle replacement (TAR) has challenged this concept.This systematic review aims
to address whether TAR or AA is optimal in terms of functional outcomes.Methods. We conducted a systematic review according
to PRISMA checklist using the online databases Medline and EMBASE after January 1, 2005. Participants must be skeletally mature
and suffering from ankle arthrosis of any cause. The intervention had to be an uncemented TAR comprising two or three modular
components. The comparative group could include any type of ankle arthrodesis, either open or arthroscopic, using any implant
for fixation. The study must have reported at least one functional outcome measure. Results. Of the four studies included, two
reported some significant improvement in functional outcome in favour of TAR. The complication rate was higher in the TAR
group. However, the quality of studies reviewed was poor and the methodological weaknesses limited any definitive conclusions
being drawn.Conclusion.The available literature is insufficient to concludewhich treatment is superior. Further research is indicated
and should be in the form of an adequately powered randomised controlled trial.
1. Introduction
End-stage ankle osteoarthritis is a debilitating condition that
results in functional limitations and a poor quality of life [1].
The incidence of symptomatic osteoarthritis of the ankle has
been estimated to be 47.7/100,000 in the United Kingdom [2].
More than 70% is related to posttraumatic osteoarthritis [1, 3]
with the majority of the remainder being primary arthritis,
inflammatory arthritis, or secondary to osteonecrosis. Mild
to moderate ankle arthritis can often be managed with
ankle foot orthoses and a rocker-bottom shoe [4]. When
surgical intervention is indicated, ankle arthrodesis (AA) has
traditionally been used. However, the development of total
ankle replacement (TAR) has challenged arthrodesis as the
treatment of choice for ankle arthrosis [5–7].
AA has been shown to give good results in multiple
papers [8–10]. Various techniques have been used which
include cannulated screws, plate fixation, retrograde nail, and
external fixation. The main drawback of the procedure is
the high rate of later arthrosis in adjacent joints, reported
between 10 and 60% [11–13]. This results in a subsequent
subtalar fusion rate at 5 years of 2.8% which is higher than
the 0.7% after TAR [14]. Additional complications associ-
ated with AA include wound infection (3–25%), nonunion
(10–20%), and malalignment [15, 16].
TAR is still evolving [17] but has the potential advantage
to preserve range of motion, restore gait, and, thus, protect
adjacent articulations [18]. The results from first generation
ankle prosthesis were disappointing with stiffness, wound
complications, loosening, malalignment, impingement, and
instability cited as causes of failure [7, 19–21]. Newer pros-
thesis is uncemented, comprises two or three modular com-
ponents, and has improved outcomes. A recent systematic
review reported 89% survival of 7942 TARs at 10 years and
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Table 1: Search strategy for Medline.
Number Search term Results
1 exp Ankle Joint/or exp Ankle/ 16259
2 exp Arthroplasty, Replacement/or exp Arthroplasty/or exp Arthroplasty, Replacement, Ankle/ 37169
3 exp Arthrodesis/ 22930
4 1 and 2 and 3 141
5 limit 4 to (english language and humans) 128
6 limit 5 to yr = “2005–Current” 88
Searches combined
N = 169
EMBASE search
N = 126
Reasons for exclusion
After abstract review
N = 14
Reasons for exclusion
Medline search
N = 88
After title review
N = 45
Secondary research: 20
Incorrect participants: 57
Incorrect intervention: 31
No comparator: 16
Secondary research: 26
Incorrect population: 2
Incorrect intervention: 1
Incorrect outcome: 1
No comparator: 1
Duplicates: 45
Figure 1: Flow diagram of review process.
an improvement in American Orthopaedic Foot and Ankle
Society score (AOFAS) from 40 to 80 at a mean of 8.2 years of
follow-up [22]. However, a further review from Gougoulias
et al. of 1105 total ankle arthroplasties reported a 10% failure
rate at 5 years with residual pain in 27%–60% of cases [23].
Haddad et al. performed a systematic review of the lit-
erature up until 2005 comparing outcomes following second
generation TAR and AA. However, the majority of the 49
studies reviewed were single centre case series and none
directly compared the two treatments. They concluded that
both techniques gave comparable intermediate and long-
term outcomes, reporting good or excellent outcomes in
68.5% of TAR and 67% of AA patients and mean AOFAS
scores of 78.2 followingTARand 75.6 followingAA.However,
variability of reporting outcomes and lack of controlled
studies restricted direct comparisons of the two groups [24].
The aim of this paper is to perform an up-to-date systematic
review of the literature including only comparative studies
addressing whether TAR or AA is optimal in the treatment
of end-stage ankle arthrosis in terms of functional outcomes.
2. Methods
We conducted a systematic review of the literature using
the online databases Medline and EMBASE. The review was
performed and reported according to the PRISMA checklist.
The search strategy used for the Medline search is shown in
Table 1 and this was modified for searching EMBASE. The
searches were carried out on January 15, 2014, and limited to
papers available in English. The search was limited to papers
published after January 1, 2005, as the previous systematic
review published in 2007 included papers prior to this date
[24].
Inclusion criteria were applied. Participants must be
skeletally mature and suffering from ankle arthrosis of any
cause deemed severe enough to warrant either TAR or
AA by the treating surgeon. The intervention had to be
an uncemented TAR comprising two or three modular
components. The comparative group could include any type
of ankle arthrodesis, either open or arthroscopic, using any
implant for fixation. The study must have reported at least
one functional outcome measure. Studies were excluded if
no comparative group was analysed or if the study partici-
pants were divided into more than two groups. In addition,
only primary research was considered for review with any
abstracts, comments, review articles, and technique articles
excluded. Eligibility of studies was assessed independently by
two authors (R.J. and G.C.) who also appraised the included
studies against the STROBE statement [25]. If there was any
disagreement between the authors in assigning a score to each
paper appraised, a third independent reviewer (A.C.) made
the final decision.
3. Results
TheMedline search revealed 88 and the EMBASE search 126
results. Figure 1 shows a flow diagram of the review process
including the reasons for exclusion at different stages of the
process. Concise details of the included studies are given in
Table 2 and the appraisal against STROBE statement [25] is
given in Table 3.The reasons for exclusion of the 10 articles at
full paper review stage are given in Table 4.
Of the four studies included, three were level III ret-
rospective comparative studies and the other was a level
II prospective comparative study. The optimal study design
when comparing two treatment modalities is a randomised
controlled trial (RCT) as this allows for minimisation of
bias. The main limitation that is common to all four studies
reviewed is the lack of randomisation; this risks selection bias
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Table 4: Reason for exclusion of studies after full paper review.
Study Reason for exclusion
[32] Expert opinion
Conley et al., 2012 [33] No functional outcome recorded
Flavin et al., 2013 [34] No functional outcome recorded
Hahn et al., 2012 [35] No functional outcome recorded
Krause and Schmid 2012 [36] No functional outcome recorded
Piriou et al., 2008 [18] No functional outcome recorded
Rouhani et at., 2011 [37] Study participants divided intomore than two groups
Rouhani et al., 2012 [38] Study participants divided intomore than two groups
Slobogean et al., 2010 [39] No functional outcome recorded
SooHoo et al., 2007 [14] No functional outcome recorded
with the uneven allocation of confounding factors between
the groups. In addition, as none of the studies reviewed
defined a primary outcome measure or included a power
calculation, uncertainty is present as to whether any of
the studies was sufficiently powered to show a significant
difference in any recorded outcome measure.
Schuh et al., 2012. Schuh et al. [26] performed a retrospective
review of 63 patients that underwent either TAR, using a
HINTEGRA prosthesis (Newdeal SA, Lyon, France), or AA,
using 3 cannulated screws. No significant difference was
found between the two groups in terms of activity level,
participation in sport, or American Orthopaedic Foot and
Ankle Society (AOFAS) hindfoot score. The surgery was
performed by a single, fellowship trained surgeon between
1998 and 2006. Of the 63 patients assessed, only 41 were
included for analysis. The 16% loss to follow-up forms a high
proportion and the majority (70%) of these were in the AA
group. The reason these patients refused follow-up is not
known and their exclusionmay have skewed results. Minimal
details of the inclusion criteria are stated andwhether patients
with arthrosis of any cause were included is not clear. Clarity
is required to decide whether results are applicable to other
populations. In addition, no mention is given as to whether
assessments were performed by an independent observer
or the postoperative physiotherapy regimen was consistent
between the two groups.
Esparragoza et al., 2011. Esparragoza et al. [27] performed a
prospective comparative study of 30 patients. Surgery was
performed by a total of 6 senior staff members of whom
3 performed all of the TAR and 3 all of the AA. All
patients undergoing TAR had the Ankle Evolution System
implant (Biomet, Nimes, France) inserted but arthrodesis
was performed by three different techniques. A statistically
significant improvement in AOFAS (𝑃 = 0.048) and SF-36
(𝑃 = 0.026) in the TAR group was reported at two years.
However, the study had a number of limitations including a
lack of randomisation and inclusion of only a small number
of patients. Although the reported baseline characteristics
are similar between the groups, further information on
adjacent joint arthrosis would have been beneficial. Those
patients undergoing arthrodesis were further divided into
three techniques, which introduces heterogeneity amongst
this arthrodesis group. Provision of outcomes for each tech-
nique would have demonstrated whether all techniques had
equal effectiveness but the low number of patients studied
precluded this. Again, details regarding the postoperative
physiotherapy regime and those responsible for measuring
outcomes should have been provided.
Krause et al., 2011.Krause et al. [28] performed a retrospective
comparative study of 161 patients. No statistically significant
difference in functional outcome was reported between the
groups; however, TAR patients had a higher complication
rate (𝑃 = 0.003). Clear indications for each procedure are
set out and details regarding the surgical technique, surgeon
experience, postoperative regime, and definitions of terms
are given. Due to strict inclusion and exclusion criteria, only
31% of patients were deemed eligible to participate limiting
the external validity of results. The authors excluded cases
where a failed arthrodesis was converted to a TAR but
included cases where a failed TAR was converted to AA.
Conversion procedures are likely to be more complex and
so, prone to worse results; the inclusion of failed TAR but
not failed AA potentially increases the complexity of cases
in the AA group and this may have impacted outcomes. The
ankle replacement used as the intervention could be one of
four prostheses depending on surgeon preference: the Agility
ankle system (Depuy, Warsaw, IN, USA), the Mobility ankle
system (Depuy,Warsaw, IN, USA), Scandinavian Total Ankle
Replacement (STAR) (Waldmar Link, Hamburg, Germany),
and HINTEGRA prosthesis (Newdeal SA, Lyon, France).
This is a pragmatic approach but the outcomes of different
prostheses may vary and this is not accounted for in the
study. Comparison between the two groups is limited by their
differences at baseline and complexity of surgery performed.
The fusion group was younger, had a lower proportion of
rheumatoid arthritis, and had a much higher proportion of
low complexity surgery (87% versus 32%); any positive results
may result from these differences rather than the type of
surgery received.
Saltzman et al., 2010. Saltzman et al. [29] performed a
retrospective comparative study of 71 patients undergoing
either TAR or AA, using a STAR (Waldmar Link, Ham-
burg, Germany). A significant improvement in the TAR
group in the pain component of Ankle Osteoarthritis Scale
(AOS) (𝑃 = 0.001) and the mental component of SF-36
(𝑃 = 0.011) was reported. Initially, 138 patients were assessed
for eligibility but 67 did not satisfy inclusion criteria and this
high number questions the external validity of results. Of the
71 included, 11 were lost to follow-up, with slightly more lost
in theAAgroup. Patients undergoingTARwith an alternative
prosthesis were excluded; in contrast, those undergoing
AA had three different surgical techniques performed. This
approach is slightly contradictory as there is an assumption
that patients having differing TAR replacements may have
varying outcomes but those having various arthrodeses
have equal outcomes. A pragmatic approach would be to
8 Advances in Orthopedics
compare all replacements versus all arthrodeses, or alter-
natively to compare one replacement against one fusion
technique. At the beginning of this section, the importance of
randomisation and transparency of treatment allocation
was discussed. In the current study, the AA group had a
higher number of young patients, males, and those with
posttraumatic arthritis. Each of these factors may directly
influence outcome and thus any positive results cannot
be confidently attributed to the treatment given. Outcome
measures have only been recorded postoperatively and the
lack of preoperative value limits the value of the results as the
degree of improvement following treatment is not known.
4. Discussion
Four studies were identified and reviewed which addressed
our research question. Two of the four studies reported
statistically significant improvements in functional outcomes
following TAR [27, 29]; the other two studies showed no
differences between the two groups [26, 28]. However, the
methodological flaws present stop definitive conclusions
being drawn.
The main limitation in design common to all studies was
the lack of randomisation. This risks differences in the study
groups being present at the point of treatment allocation
which has the potential to affect results. Only one study
described the indications for the two procedures [28], using
severe deformity or instability, poor anklemotion, no ormild
adjacent joint arthritis, and younger age as indications of
arthrodesis. Therefore, the arthrodesis group in this study
will have had a higher proportion of patients with these
factors than the TAR group, which all may have influenced
outcomes.The other three studies [26, 27, 29] do not describe
the indications used for allocation but it is likely that baseline
characteristics also differed in these studies, limiting the
ability to directly compare outcomes between the two groups.
A further limitation of the systematic review is the use of
pragmatic entry criteria for the intervention and comparator
groups, with all arthrodesis procedures and any uncemented
ankle replacement included. The four studies included used
five different uncemented ankle prostheses and four fixation
methods for arthrodesis including open and arthroscopic
techniques. The inclusion of numerous surgical techniques
restricts the generalisability of the results to any specific
technique as it is likely that the outcomes following each
method differ.
Although at least one functional outcome was measured
in each study, the evidence supporting the validity, reliability,
and responsiveness of the available measures following foot
and ankle surgery is limited [30, 31]. The AOFAS is the most
commonly used outcome measure following foot and ankle
surgery [30, 31] but it relies on the observer to measure both
range ofmotion andmalalignment, risking observer bias.The
AOS is patient reported which reduces the risk of observer
bias and has been validated in ankle osteoarthritis, but it is not
validated in the measurement of outcome following AA or
TAR. Therefore, neither of the two functional measures pro-
vides an ideal measurement tool and may have contributed
to inaccurate recording of outcomes. Future research should
utilise an outcome tool that both is patient reported and is
validated for use in this postoperative population.
At present, the evidence is insufficient to change clinical
practice. Arthrodesis has been the traditional treatment of
choice and will continue to be so until the literature defini-
tively demonstrates one modality to be superior to the other.
The increased rate of complications reported following TAR
further supports this approach [28]. Ideally, future research
will be of RCT design so that selection bias is limited and
effects measured can be attributed to treatment allocation.
The population treated needs to be clearly defined so that
results can be applied to the readers’ practice. They should
have a patient reported outcome as the defined primary
outcome and the study should be adequately powered to show
a statistically significant difference between the groups.
5. Conclusion
Although half of the reviewed studies report some functional
improvement following total ankle replacement, the lack of
high quality evidence limits a definitive conclusion being
drawn. Insufficient evidence is available to decide whether
total ankle replacement or ankle arthrodesis improves func-
tional outcomes and further research in the form of robust
RCTs is indicated.
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